Format

Send to

Choose Destination
J Pharm Sci. 2016 Sep;105(9):2921-2931. doi: 10.1016/j.xphs.2016.04.034. Epub 2016 Jun 14.

"Back to the Future": A New Look at Hydroxypropyl Beta-Cyclodextrins.

Author information

1
CycloLab Cyclodextrin Research & Development Ltd, Budapest, Hungary H-1097.
2
CycloLab Cyclodextrin Research & Development Ltd, Budapest, Hungary H-1097. Electronic address: fenyvesi.e@cyclolab.hu.
3
Inorganic and Analytical Chemistry, Faculty of Sciences and Technology, University of Debrecen, Hungary, H-4032.
4
Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Debrecen, Debrecen, Hungary.

Abstract

Since the discovery about 30 years ago (2-hydroxypropyl) beta-cyclodextrin, a highly soluble derivative of beta-cyclodextrin, has become an approved excipient of drug formulations included both in the United States and European Pharmacopoeias. It is recommended to use as solubilizer and stabilizer for oral and parenteral formulations. Recently, its pharmacological activity has been recognized in various diseases. The increasing applications require a closer look to the structure-activity relationship. As (2-hydroxypropyl) beta-cyclodextrin (HPBCD) is always a mixture of isomers with various degrees and pattern of hydroxypropylation, no wonder that the products of different manufacturers are often different. Several HPBCDs were compared applying a battery of analytical tools including thin layer chromatography, high performance liquid chromatography (HPLC), HPLC-mass spectrometry (MS), and matrix-assisted laser desorption MS. We studied how the average degree of substitution affects the aggregation behavior, the toxicity, and the solubilizing effect on poorly soluble drugs. We found that the products with low average degree of substitution are more prone to aggregation. The samples studied are nontoxic to Caco-2 cells and have low hemolytic activity. The solubility enhancement of poorly soluble drugs decreases or increases with increasing degree of substitution or shows a maximum curve depending on the properties of the guest.

KEYWORDS:

HPLC; NMR; biocompatibility; cyclodextrins; drug delivery; inclusion compounds; light scattering; solubility

PMID:
27317368
DOI:
10.1016/j.xphs.2016.04.034
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center